Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Lockdown in England could be extended, UK minister warns

Sun, 01st Nov 2020 09:54

* England's month-long lockdown could be extended, Gove says

* Health service would be overwhelmed without action now -
Gove

* Details of financial support to be announced in coming
days

* Labour's Starmer says UK spurned chance to lockdown
earlier
(Adds details from Gove, scientific adviser, economic context)

By Andy Bruce

LONDON, Nov 1 (Reuters) - The one-month lockdown for England
announced by Prime Minister Boris Johnson this weekend could be
extended as Britain struggles to contain a second wave of the
COVID-19 pandemic, a senior cabinet member said on Sunday.

After resisting the prospect of a new national lockdown for
most of last month, Johnson announced on Saturday that new
restrictions across England would kick in after midnight on
Thursday morning and last until Dec. 2.

The United Kingdom, which has the biggest official death
toll in Europe from COVID-19, is grappling with more than 20,000
new coronavirus cases a day and scientists have warned a
worst-case scenario of 80,000 dead this winter could be
exceeded.

Asked if a lockdown could be extended beyond early December,
senior cabinet minister Michael Gove told Sky News: "Yes."

So far, Britain has reported 46,555 COVID-19 deaths -
defined as those dying within 28 days of a positive test. A
broader measure of those with COVID-19 on their death
certificates puts the toll at 58,925.

"We can definitively say that unless we take action now, the
(health service) is going to be overwhelmed in ways that none of
us could countenance," Gove said.

The new lockdown announcement came 10 days after Johnson
told parliament it would "make no sense at all" to "turn the
lights out with a full national lockdown".

Critics have accused him of dithering at the expense of both
lives and the economy.

Opposition Labour Party leader Keir Starmer said the
government had missed a golden chance to lock down England more
effectively when schools were on half-term break last month.

"Well that's gone now. That is the price of the government's
incompetence," Starmer told the BBC.

The other constituents of the United Kingdom - Scotland,
Wales and Northern Ireland - have their own policies and enacted
tougher COVID-19 health restrictions last month.

EXTRA FINANCIAL SUPPORT

Government scientific adviser Jeremy Farrar said on Sunday
the lockdown would need to be extended beyond early December in
absence of evidence of a shrinking pandemic.

"Much better to do that than remove these restrictions and
then have to reimpose even more draconian restrictions around
Christmas or soon into the new year," he told the BBC.

Farrar said he had high hopes that vaccines would make a big
difference to the pandemic next year, even if they might not be
perfect.

British drugmaker AstraZeneca said on Sunday
Britain's health regulator had started an accelerated review of
its potential coronavirus vaccine.

Gove said the government would publish more information in
the coming days about extra financial support for businesses and
households, including the month-long extension to the furlough
scheme that had been scheduled to close on Saturday.

The new measures are likely to add substantially to the
roughly 200 billion pounds of emergency spending already
committed by finance minister Rishi Sunak to keep the world's
sixth-biggest economy afloat.

It is on course to contract 10% this year, which would be
its worst performance since the early 1700s, according to the
latest Reuters poll of economists conducted before the latest
lockdown announcement.

The survey showed the Bank of England is likely to announce
a 100 billion-pound expansion of its bond buying stimulus on
Thursday.
(Reporting by Andy Bruce; Editing by Angus MacSwan and Raissa
Kasolowsky)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.